MicroPort Scientific (HKG:0853) said it was considering consolidating its cardiac rhythm management business with MicroPort CardioFlow Medtech (HKG:2160), according to a Hong Kong bourse filing Wednesday.
Shares of MicroPort CardioFlow gained 9% in morning trade Thursday, while MicroPort Scientific rose nearly 5%.
Under the proposal, MicroPort's CRM business under its 50.13%-owned MicroPort Cardiac Rhythm Management subsidiary will be combined with MicroPort CardioFlow, which oversee's the group's structural heart disease business.
MicroPort Scientific cautioned that the proposal was non-binding and subject to a number of conditions.
Meanwhile, MicroPort CardioFlow said it was evaluating the proposal and would inform the market with relevant updates.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。